Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The landscape of treating type 2 diabetes and obesity has been significantly reshaped by the advent of GLP-1 receptor agonists (GLP-1RAs). Among the most impactful of these is Semaglutide, a highly effective medication that has brought new hope to millions. The development and availability of such transformative drugs depend heavily on the precise synthesis of their core components, with Semaglutide Intermediate P29 (GLP-1(9-37)) playing a crucial role.
From Intermediate to Therapeutic Breakthrough
Semaglutide Intermediate P29, often referred to as the peptide backbone or main chain, is the foundational peptide sequence required for the synthesis of Semaglutide API. Its structure is meticulously crafted to ensure the final drug molecule achieves its desired pharmacological activity. By acting as a GLP-1 analogue, Semaglutide mimics the natural incretin hormone, stimulating insulin secretion, suppressing glucagon release, and slowing gastric emptying, all of which contribute to improved glycemic control and appetite suppression.
Impact on Type 2 Diabetes Management
For patients with type 2 diabetes, Semaglutide has offered a powerful tool to manage blood sugar levels. Clinical trials have consistently demonstrated its efficacy in achieving significant reductions in HbA1c levels, often surpassing those of older antidiabetic medications. Beyond glucose control, its cardiovascular benefits and weight loss potential further enhance its therapeutic value, addressing multiple facets of the disease complex.
Addressing the Obesity Epidemic
Recognizing the profound impact of obesity on overall health, Semaglutide has also been approved for chronic weight management. Its ability to induce substantial and sustained weight loss has positioned it as a game-changer for individuals struggling with overweight and obesity, along with their associated comorbidities such as hypertension and dyslipidemia. The efficacy seen in weight management has opened new avenues for research into its application in various metabolic disorders.
The Importance of a Reliable Intermediate Supplier
The widespread adoption and success of Semaglutide underscore the critical importance of its production. Pharmaceutical companies rely on dependable manufacturers and suppliers of Semaglutide Intermediate P29 to ensure an uninterrupted supply chain. By offering high-purity, GMP-compliant intermediates, companies like ours enable the continued development and accessibility of these vital therapies. When seeking to buy this intermediate, partnering with a trusted entity ensures that the journey from chemical synthesis to therapeutic impact is seamless and secure.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
